ESC Premium Access

Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)

Congress Presentation

About the speaker

Doctor Manan Pareek

Herlev and Gentofte Hospital, Copenhagen (Denmark)
1 presentation
0 follower

110 more presentations in this session

Exercise intensities modulate cognitive function in spontaneously hypertensive rats through oxidative mediated synaptic plasticity in hippocampus

Speaker: Professor T. Lee (Tainan, TW)


Arterial stiffness and the risk of heart failure formation in rotational shift workers in the arctic

Speaker: Doctor N. Shurkevich (Tyumen, RU)


Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial

Speaker: Doctor M. Pareek (Copenhagen, DK)


Renal denervation in truly resistant hypertensive patients: six-year follow-up results of a single-center study

Speaker: Doctor M. Ionov (Saint Petersburg, RU)


Evaluation of global left ventricular systolic function in dipper and newly diagnosed nondipper hypertensive patients

Speaker: Doctor S. CAKAL (Istanbul, TR)


Access the full session

Hypertension e-posters

Speakers: Doctor M. Pareek, Professor T. Lee, Doctor N. Shurkevich, Doctor M. Pareek, Doctor M. Ionov...

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

27 August 2021

ESC 365 is supported by

logo Novo Nordisk